Literature DB >> 28677601

A novel tubular hydrogen-bond pattern in a new diazaphosphole oxide: a combination of X-ray crystallography and theoretical study of hydrogen bonds.

Fahimeh Sabbaghi1, Mehrdad Pourayoubi2, Abolghasem Farhadipour3, Nazila Ghorbanian4, Pavel V Andreev5.   

Abstract

In the structure of 2-(4-chloroanilino)-1,3,2λ4-diazaphosphol-2-one, C12H11ClN3OP, each molecule is connected with four neighbouring molecules through (N-H)2...O hydrogen bonds. These hydrogen bonds form a tubular arrangement along the [001] direction built from R33(12) and R43(14) hydrogen-bond ring motifs, combined with a C(4) chain motif. The hole constructed in the tubular architecture includes a 12-atom arrangement (three P, three N, three O and three H atoms) belonging to three adjacent molecules hydrogen bonded to each other. One of the N-H groups of the diazaphosphole ring, not co-operating in classical hydrogen bonding, takes part in an N-H...π interaction. This interaction occurs within the tubular array and does not change the dimension of the hydrogen-bond pattern. The energies of the N-H...O and N-H...π hydrogen bonds were studied by NBO (natural bond orbital) analysis, using the experimental hydrogen-bonded cluster of molecules as the input file for the chemical calculations. In the 1H NMR experiment, the nitrogen-bound proton of the diazaphosphole ring has a high value of 17.2 Hz for the 2JH-P coupling constant.

Entities:  

Keywords:  DFT; computational chemistry; crystal structure; diazaphosphole oxide; natural bond orbital; tubular hydrogen-bond pattern

Year:  2017        PMID: 28677601     DOI: 10.1107/S205322961700794X

Source DB:  PubMed          Journal:  Acta Crystallogr C Struct Chem        ISSN: 2053-2296            Impact factor:   1.172


  1 in total

1.  The (CF3C(O)NH)(C6H5CH2NH)2P(O) phosphoric triamide as a novel carrier with excellent efficiency for Cu(ii) in a liquid membrane transport system.

Authors:  Setareh Akbari; Razieh Sanavi Khoshnood; Fatemeh Karimi Ahmadabad; Mehrdad Pourayoubi; Michal Dušek; Ekaterina S Shchegravina
Journal:  RSC Adv       Date:  2019-03-19       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.